K12 Career Development
K12职业发展
基本信息
- 批准号:8333429
- 负责人:
- 金额:$ 36.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-16 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAreaAutoimmune ProcessAutoimmunityBasic ScienceBehavioral ResearchBiochemicalBiochemistryCell physiologyCenter for Translational Science ActivitiesChildhoodCitiesClinicalClinical ResearchClinical SciencesColoradoCountryDiabetes MellitusDoctor of PhilosophyDrug KineticsEndocrinologistEpidemicEpidemiologic StudiesEpidemiologyEthicsFacultyFunctional disorderFundingGeneticHealthcareHumanHuman GeneticsImmune ToleranceImmunobiologyImmunologyInsulin-Dependent Diabetes MellitusInvestigationIslet CellMaster of ScienceMedicalMedical GeneticsMedical ResearchMedicineMentorsMolecular BiologyMolecular GeneticsNamesNon-Insulin-Dependent Diabetes MellitusPediatric HospitalsPhysiciansPopulationPreventionPublic HealthPublic Health SchoolsPublished CommentRegulationResearchResearch InstituteResearch MethodologyResearch PersonnelResearch TrainingRoleSECTM1 geneScientistTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkWritingcareer developmentdesignexperiencehealth economicsimprovedmedical schoolsmultidisciplinarynext generationpediatric departmentprogramsstatisticstype I and type II diabetes
项目摘要
DESCRIPTION (provided by applicant): This application is a proposal for a career development program for pediatric endocrinologists, designed to provide multidisciplinary training in diabetes research at The Barbara Davis Center (BDC), The University of Colorado School of Medicine (UC SOM) and the wider Anschutz Medical Campus (AMC). The proposal's rationale is: 1) there is a critical shortage of pediatric endocrinologists in the country, particuarly those trained and experienced in type 1 diabetes research 2) Diabetes is an increasingly significant healthcare problem in the pediatric population with devastating consequences from a personal and health economics viewpoint 3) Current rapid advances in diabetes investigation calls for an increased pool of physician scientists trained in clinical, biochemical, epidemiological, and behavioral research to carry out basic and translational research in pediatric type 1 and type 2 diabetes to bring advances in diabetes research to the clinical arena. The Barbara Davis Center has extensive and a proven record in research training of young investigators. The BDC and AMC have a well -established network of investigators working in the epidemiology, immunobiology, genetics, and molecular biology of type 1 diabetes, as well as the abnormal pathophysiology of type 2 diabetes. This network of experienced mentors is ideally suited to develop the next generation of young pediatric endocrinologists into independent diabetes investigators in high impact type 1 diabetes research. Areas of research focus within The Barbara Davis Center include islet cell physiology, genetics, molecular biology, immunology, the autoimmunity, prediction and prevention of type 1 diabetes, and the epidemiology, prevention and improved treatment of type 1 and type 2 diabetes. These areas of research are urgently needed and have been identified as important to the national public health to address the epidemic of diabetes in the US. This application is enhanced by the NIH supported Colorado Clinical and Translational Research Institute (CCTSI), Pediatric and Adult Clinical Translational Research Centers, as well as a strong Masters of Science in Public Health Program and in Clinical Science and PhD programs in the Colorado School of Public Health (CSPH) and within the CCTSI. This application has the support of the Departments of Pediatrics, Medicine, The CSPH, and The Children's Hospital of Denver. The ability to provide strong didactic coursework in statistics, epidemiology, research methods, ethics and regulation of human research, medical writing, biochemistry, pharmacokinetics and molecular biology, as well as human medical genetics and molecular genetics through the CCTSI, the BDC, the Program in Human Genetics and the cSPH, combined with a strong mentoring faculty at the BDC and UCSOM will allow us to provide the career development for young pediatric endocrinologists producing independent investigators, capable of competing for funding in high quality diabetes research. Other programs within UC SOM that are supportive of this program include the Program in Human Genetics, The Immune Tolerance Network, the Autoimmune Prevention Center and Children's Hospital Research Institute. PERFORMANCE SITE(S) (organization, city, state) The University of Colorado Denver, Denver, Colorado The Barbara Davis Center for Childhood Diabetes, Denver, Colorado KEY PERSONNEL. Name: Klingensmith, Georgeanna Organization: Barbara Davis Center, University of Colorado Denver Role on Project: Program Director
描述(由申请人提供):本申请是儿科内分泌学家职业发展计划的提案,旨在为芭芭拉戴维斯中心(BDC),科罗拉多大学医学院(UC SOM)和更广泛的安舒茨医学院(AMC)提供糖尿病研究方面的多学科培训。这项建议的理由是:1)国内儿科内分泌专家严重短缺,特别是那些在1型糖尿病研究方面受过培训和经验丰富的人2)从个人和健康经济学的角度来看,糖尿病是儿科人口中日益重要的医疗保健问题,具有毁灭性的后果3)当前糖尿病研究的快速进展要求增加临床,生化,流行病学,以及行为研究,开展儿科1型和2型糖尿病的基础和转化研究,将糖尿病研究的进展带入临床领域。芭芭拉·戴维斯中心在年轻研究人员的研究培训方面有着广泛而可靠的记录。BDC和AMC在1型糖尿病的流行病学、免疫生物学、遗传学和分子生物学以及2型糖尿病的异常病理生理学方面有一个完善的研究网络。这个由经验丰富的导师组成的网络非常适合将下一代年轻的儿科内分泌学家培养成具有高影响力的1型糖尿病研究的独立糖尿病研究者。芭芭拉戴维斯中心的研究重点包括胰岛细胞生理学、遗传学、分子生物学、免疫学、自身免疫、1型糖尿病的预测和预防,以及1型和2型糖尿病的流行病学、预防和改进治疗。这些领域的研究是迫切需要的,并且已被确定为对国家公共卫生至关重要,以解决美国糖尿病的流行。这一应用得到了美国国立卫生研究院支持的科罗拉多临床和转化研究所(CCTSI)、儿科和成人临床转化研究中心的加强,以及科罗拉多公共卫生学院(CSPH)和CCTSI内部的公共卫生项目、临床科学和博士项目的强大硕士学位。该应用程序得到了儿科、医学部、CSPH和丹佛儿童医院的支持。有能力通过CCTSI、BDC、人类遗传学项目和cSPH,在统计学、流行病学、研究方法、人类研究的伦理和监管、医学写作、生物化学、药代动力学和分子生物学,以及人类医学遗传学和分子遗传学方面提供强有力的教学课程。结合BDC和UCSOM强大的指导教师,我们将为年轻的儿科内分泌学家提供职业发展,培养独立的研究者,有能力在高质量的糖尿病研究中竞争资金。加州大学管理学院的其他项目也支持这个项目,包括人类遗传学项目、免疫耐受网络、自身免疫预防中心和儿童医院研究所。演出地点(组织,城市,州)科罗拉多州丹佛市的科罗拉多大学科罗拉多州丹佛市的芭芭拉·戴维斯儿童糖尿病中心,丹佛市,科罗拉多州关键人员。姓名:Klingensmith, Georgeanna组织:Barbara Davis中心,科罗拉多大学丹佛分校项目角色:项目主管
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGEANNA J KLINGENSMITH其他文献
GEORGEANNA J KLINGENSMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGEANNA J KLINGENSMITH', 18)}}的其他基金
Diabetes Research for Pediatric Endocrinologists
儿科内分泌学家的糖尿病研究
- 批准号:
6666711 - 财政年份:2002
- 资助金额:
$ 36.89万 - 项目类别:
Diabetes Research for Pediatric Endocrinologists
儿科内分泌学家的糖尿病研究
- 批准号:
6584802 - 财政年份:2002
- 资助金额:
$ 36.89万 - 项目类别:
相似海外基金
History of Community and Adult Education in Old Coal Mining Area in Northern Kyushu
九州北部老煤矿区社区与成人教育的历史
- 批准号:
26780447 - 财政年份:2014
- 资助金额:
$ 36.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
High Risk Adult Hepatitis B Vaccination Pilot -Program Area 7
高危成人乙型肝炎疫苗接种试点 - 计划领域 7
- 批准号:
8506903 - 财政年份:2012
- 资助金额:
$ 36.89万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7253800 - 财政年份:2007
- 资助金额:
$ 36.89万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
6686704 - 财政年份:2002
- 资助金额:
$ 36.89万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
8258656 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550487 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
8099448 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550482 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7885642 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550492 - 财政年份:
- 资助金额:
$ 36.89万 - 项目类别: